LMAT LeMaitre Vascular · $101.63 Neutral — no clear edge中性 — 无明显优势 Terminal终端
LeMaitre Vascular · Health Care

LMAT

$101.63
LeMaitre Vascular is an American medical device company established in 1986 by vascular surgeon George D. LeMaitre, and based in Burlington, Massachusetts, which provides devices, implants and human tissue cryopreservation services used by surgeons in the treatment of vascular conditions,...LeMaitreVascular是一家美国医疗器械公司,由血管外科医生GeorgeD.LeMaitre于1986年创立,总部位于马萨诸塞州伯灵顿,提供外科医生治疗血管疾病(尤其是外周血管疾病)时使用的器械、植入物及人体组织冷冻保存服务。
Rate-sensitive利率敏感 Mid cap中盘 $2B
Engine stance引擎立场2026-07-20
Neutral — no clear edge中性 — 无明显优势
Daily low forming, but the bigger trend is still bearish. Small size only; stop below 88.61.日线低点正在形成,但大趋势仍偏空。只适合小仓位;止损设于 88.61 下方。
Open in Terminal打开终端 All coverage所有股票 Data through数据截至 2026-07-20 · regenerated nightly每日更新

Key Statistics关键统计

Price价格
$101.63
13.2% below 52-week high低于52周高点 13.2%
Market Cap市值
$2B
Normal volume正常成交量
P/E Ratio市盈率
40.1x
28.9x sector median
Beta贝塔
0.54
Moves about 0.5x the market波动幅度约为市场的 0.5 倍
RSI (14)RSI(14)
55
Neutral zone中性区域
Next Earnings下次财报
2026-08-04 (16d)
Volatility Rank波动率分位
92th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
6.0% of float

Performance价格表现

Period周期 LMAT S&P 500vs Index对比指数
1 Week近1周 -1.1% -1.5% In line with the index与指数基本持平
1 Month近1月 +10.2% +0.6% Beat the index by 9.6 points跑赢指数 9.6 个百分点
3 Months近3月 -10.9% +4.7% Lagged the index by 15.6 points落后指数 15.6 个百分点
6 Months近6月 +15.7% +7.8% Beat the index by 7.9 points跑赢指数 7.9 个百分点
Year to date年初至今 +27.4% +9.1% Beat the index by 18.3 points跑赢指数 18.3 个百分点
1 Year近1年 +24.9% +19.4% Beat the index by 5.5 points跑赢指数 5.5 个百分点
3 Years近3年 +59.0% +69.4% Lagged the index by 10.4 points落后指数 10.4 个百分点

Technicals技术面

RSI (14)RSI(14) 55 Neutral zone中性区域
vs 50-day相对50日均线 +4.1% vs 50-day avg
vs 200-day相对200日均线 +7.4% vs 200-day avg
Volatility rank波动率分位 92th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$98.45
Don't chase above不追高于
$101.60
Stop止损
$88.61
Bounce — turn not confirmed; wait反弹 — 转向未确认,先观望

Earnings财务业绩

16
days until next report天后公布财报
2026-08-04

Estimates being raised — 8 analysts预期上调 — 8 位分析师

Earnings call transcripts — coming soon财报电话会议记录 — 即将上线

Valuation估值

Multiple指标 LMAT Sector median行业中位 Cheaper than相对便宜
P/E (trailing)市盈率(历史) 40.11x 28.92
26%
P/B市净率 5.88x 3.52
26%
P/S市销率 9.27x 3.02
12%
Earnings yield盈利收益率 2.49% 2.72
46%
FCF yield自由现金流收益率 3.22% 3.94
40%
Shareholder yield股东收益率 0.86% 1.89
31%
EV/EBITDA企业价值/EBITDA 29.19x 18.21
21%
P/FCF市值/自由现金流 31.08x 22.42
30%
Analyst price targets — coming soon分析师目标价 — 即将上线

Financials财务数据

Revenue营业收入
$129.4M
2020
$154.4M
2021
$161.7M
2022
$193.5M
2023
$219.9M
2024
$249.6M
2025
5yr CAGR5年复合增速: 14.0%
Earnings Per Share每股收益
$1.04
2020
$1.25
2021
$0.93
2022
$1.34
2023
$1.93
2024
$2.52
2025
5yr CAGR5年复合增速: 19.4%
Free Cash Flow自由现金流
$31.8M
2020
$30.2M
2021
$22.1M
2022
$29.5M
2023
$37.2M
2024
$74.5M
2025
Margins利润率
Gross margin毛利率
71.5%
Operating margin营业利润率
27.2%
Net margin净利率
23.1%
FCF margin自由现金流利润率
32.6%
14.7%Return on Equity股本回报率
9.4%Return on Assets资产回报率
Leverage杠杆
Net debt / EBITDA净债务/EBITDA-0.36
Current ratio流动比率12.89
Capital Allocation资本配置
Buybacks (TTM)回购(TTM)$1.8M
Stock-based comp股权薪酬$7.8M
Share count change (1y)股数变化(1年)+1.0%
Piotroski皮奥特罗斯基 6/7 Altman Z阿尔特曼Z: safe (8.3) Clean稳健

Snapshot Gauges综合指标

Valuation vs Sector估值相对行业
Expensive vs sector相对行业偏贵
Cheaper than 25% of its sector on blended multiples综合估值倍数低于行业内 25% 的公司
Beta市场敏感度
0.54×
0.2
Moves about 0.5× the market波动幅度约为市场的 0.5 倍
Financial Health财务健康
6/7
Altman阿尔特曼: safe
Adequate financial health财务健康状况一般
Dividend分红
Does not pay a dividend不派发股息

Why Is It Moving为何波动

Macro宏观 Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓 Insider cluster activity内部人集中交易
Technical技术面 NEARING A LOW → BOTTOMING接近低点 → 筑底中

Ownership & Smart Money持仓与聪明钱

Insider activity内部人员活动: -$23.7M net (0 buyers, 3 sellers)-$23.7M 净值(0 买家,3 卖家)

Signal History信号历史

BOTTOMING → UNCONFIRMED TURN筑底中 → 未确认转向
HIGH-RISK · NIMBLE ONLY. A daily bottoming setup is forming (swing low in, momentum turned up) — but the higher timeframes haven't confirmed it: the bigger picture is still bearish (weekly momentum curling up; investor cycle overdue; last cycle left-translated (topped early)). This is an UNCONFIRMED TURN, not a confirmed buy. Weekly confirmation lags price, so this exact reading covers BOTH bounces that fail AND the first leg of a genuine new cycle — you can't tell which in real time, so treat it as a risk/size signal, not a direction call. Measured: weekly-unconfirmed bottoming setups held the low ~49% of the time vs ~68% once the weekly turns up. Last cycle was left-translated (topped early) — a bearish structural tell高风险 · 仅限灵活操作。正在形成日线筑底形态(摆动低点已现、动量转向上行)——但更高周期尚未确认:大局仍偏空(周线动量开始上翘;投资者周期已逾期;上一周期左移(见顶偏早))。这是「未确认转向」,并非已确认的买入。周线确认滞后于价格,因此同样的读数既涵盖最终失败的反弹,也涵盖真正新周期的第一段——实时无法判定属于哪一种,故应将其视为风险/仓位信号,而非方向判断。实测:周线未确认的筑底形态约 49% 守住低点,周线转向后升至约 68%。 上一周期为左移结构(见顶偏早)——属于看空的结构性信号
COUNTERTREND BOUNCE UNCONFIRMED TURN
Jul 14, 2026
NEARING A LOW → BOTTOMING接近低点 → 筑底中
BUY SETUP买入预备
Jul 13, 2026
UPTREND → NEARING A LOW上涨趋势 → 接近低点
GET READY准备
Jul 10, 2026
BOTTOMING → UPTREND筑底中 → 上涨趋势
HOLD持有
Jul 7, 2026
UNCONFIRMED TURN → BOTTOMING未确认转向 → 筑底中
BUY SETUP买入预备
Jun 25, 2026
LMAT reclaimed its 200-day averageLMAT 收复200日均线
Price closed back above the 200-day moving average — the classic bull dividing line. $93.93.收盘重回200日均线 — 经典的多头分界线。$93.93。
Jun 24, 2026
NEARING A LOW → UPTREND接近低点 → 上涨趋势
HOLD持有
Jun 23, 2026
DOWNTREND → NEARING A LOW下跌趋势 → 接近低点
GET READY准备
Jun 23, 2026
DOWNTREND → UNCONFIRMED TURN下跌趋势 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作

Showing last 15 of显示最近15条,共 258 signals条信号

Factor Profile因子特征

Composite factor score综合因子得分: -0.33
Value价值
-0.8
Profitability盈利能力
-0.1
Quality质量
-0.1
Investment资本投入
-0.2
Shareholder payout股东回报
-0.8
Low volatility低波动
+0.0
Low market beta低市场敏感度
+0.4
Earnings quality盈利质量
-0.1
Short interest空头兴趣
+0.2

Company Profile公司档案

LeMaitre Vascular is an American medical device company established in 1986 by vascular surgeon George D. LeMaitre, and based in Burlington, Massachusetts, which provides devices, implants and human tissue cryopreservation services used by surgeons in the treatment of vascular conditions,...LeMaitreVascular是一家美国医疗器械公司,由血管外科医生GeorgeD.LeMaitre于1986年创立,总部位于马萨诸塞州伯灵顿,提供外科医生治疗血管疾病(尤其是外周血管疾病)时使用的器械、植入物及人体组织冷冻保存服务。
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析,覆盖所有标普500成分股。